Utrecht Centre for

Pharmaceutical Policy and Regulation

June 8th, 2015

Apotheker maakt zelf weesgeneesmiddel
June 8th, 2015

Translation of rare disease research into orphan drug development: disease matters
June 8th, 2015

Pharmacovigilance of biosimilars from a regulatory point of view: Is there a need for specific approach?
June 8th, 2015

Pharmacovigilance of Biopharmaceuticals, Challenges Remain
June 8th, 2015

Evaluation of Post-Authorization Safety Studies in the First Cohort of EU Risk Management Plans at Time of Regulatory.
June 8th, 2015

Regulatory scientific advice in drug development: does company size make a difference?
June 8th, 2015

Superior efficacy of new medicines?
June 8th, 2015

Safety-Related Regulatory Actions for Orphan Drugs in the US and EU: A Cohort Study